Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-02

Clinical Trial Update: Pentoxifylline in Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 trial of pentoxifylline for lupus nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: MetroHealth Medical Center | Conditions: Lupus Nephritis | Phase 4 | Status: WITHDRAWN